Companies in #Cardiovascular Rare Disease

Kardigan is a clinical-stage cardiovascular biotechnology company founded by Tassos Gianakakos, the former CEO of MyoKardia (acquired by Bristol-Myers Squibb for $13B), with a portfolio of in-licensed cardiovascular drug candidates targeting cardiomyopathies and related heart conditions.